[1] |
Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease[J]. Neuro Oncol, 2021, 23(9): 1447-1456. DOI: 10.1093/neuonc/noab101.
doi: 10.1093/neuonc/noab101
|
[2] |
Garsa A, Jang JK, Baxi S, et al. Radiation therapy for brain metastases: a systematic review[J]. Pract Radiat Oncol, 2021, 11(5): 354-365. DOI: 10.1016/j.prro.2021.04.002.
doi: 10.1016/j.prro.2021.04.002
pmid: 34119447
|
[3] |
July J, Pranata R. Hypofractionated versus single-fraction stereotactic radiosurgery for the treatment of brain metastases: a systematic review and meta-analysis[J]. Clin Neurol Neurosurg, 2021, 206: 106645. DOI: 10.1016/j.clineuro.2021.106645.
doi: 10.1016/j.clineuro.2021.106645
|
[4] |
Masucci GL. Hypofractionated radiation therapy for large brain metastases[J]. Front Oncol, 2018, 8: 379. DOI: 10.3389/fonc.2018.00379.
doi: 10.3389/fonc.2018.00379
pmid: 30333955
|
[5] |
Sarmey N, Kaisman-Elbaz T, Mohammadi AM. Management strategies for large brain metastases[J]. Front Oncol, 2022, 12: 827304. DOI: 10.3389/fonc.2022.827304.
doi: 10.3389/fonc.2022.827304
|
[6] |
Tonse R, Tom MC, Mehta MP, et al. Integration of systemic therapy and stereotactic radiosurgery for brain metastases[J]. Cancers (Basel), 2021, 13(15): 3682. DOI: 10.3390/cancers13153682.
doi: 10.3390/cancers13153682
|
[7] |
Lupattelli M, Tini P, Nardone V, et al. Stereotactic radiotherapy for brain oligometastases[J]. Rep Pract Oncol Radiother, 2022, 27(1): 15-22. DOI: 10.5603/RPOR.a2021.0133.
doi: 10.5603/RPOR.a2021.0133
|
[8] |
周冲, 郭汝元, 夏铀铀, 等. 基于直线加速器的分次立体定向放疗在脑寡转移肿瘤中的应用[J]. 肿瘤研究与临床, 2020, 32(11): 741-744. DOI: 10.3760/cma.j.cn115355-20200401-00166.
doi: 10.3760/cma.j.cn115355-20200401-00166
|
[9] |
中国放射性脑损伤多学科协作组; 中国医师协会神经内科分会脑与脊髓损害专业委员会. 放射性脑损伤诊治中国专家共识[J]. 中华神经医学杂志, 2019, 18(6): 541-549. DOI: 10.3760/cma.j.issn.1671-8925.2019.06.001.
doi: 10.3760/cma.j.issn.1671-8925.2019.06.001
|
[10] |
Mohammadi AM, Schroeder JL, Angelov L, et al. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases[J]. J Neurosurg, 2017, 126(3): 735-743. DOI: 10.3171/2016.3.JNS153014.
doi: 10.3171/2016.3.JNS153014
pmid: 27231978
|
[11] |
Baschnagel AM, Meyer KD, Chen PY, et al. Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery[J]. J Neurosurg, 2013, 119(5): 1139-1144. DOI: 10.3171/2013.7.JNS13431.
doi: 10.3171/2013.7.JNS13431
pmid: 23971958
|
[12] |
Vogelbaum MA, Brown PD, Messersmith H, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline[J]. J Clin Oncol, 2022, 40(5): 492-516. DOI: 10.1200/JCO.21.02314.
doi: 10.1200/JCO.21.02314
|
[13] |
Gondi V, Bauman G, Bradfield L, et al. Radiation therapy for brain metastases: an ASTRO clinical practice guideline[J]. Pract Radiat Oncol, 2022, 12(4): 265-282. DOI: 10.1016/j.prro.2022.02.003.
doi: 10.1016/j.prro.2022.02.003
pmid: 35534352
|
[14] |
Remick JS, Kowalski E, Khairnar R, et al. A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis[J]. Radiat Oncol, 2020, 15(1): 128. DOI: 10.1186/s13014-020-01522-6.
doi: 10.1186/s13014-020-01522-6
pmid: 32466775
|
[15] |
Zhou C, Xia Y, Huang P, et al. Fractionated stereotactic radiation therapy using volumetric modulated arc therapy in patients with solitary brain metastases[J]. Biomed Res Int, 2020, 2020: 6342057. DOI: 10.1155/2020/6342057.
doi: 10.1155/2020/6342057
|
[16] |
Myrehaug S, Hudson J, Soliman H, et al. Hypofractionated stereotactic radiation therapy for intact brain metastases in 5 daily fractions: effect of dose on treatment response[J]. Int J Radiat Oncol Biol Phys, 2022, 112(2): 342-350. DOI: 10.1016/j.ijrobp.2021.09.003.
doi: 10.1016/j.ijrobp.2021.09.003
|
[17] |
Milano MT, Grimm J, Niemierko A, et al. Single- and multifraction stereotactic radiosurgery dose/volume tolerances of the brain[J]. Int J Radiat Oncol Biol Phys, 2021, 110(1): 68-86. DOI: 10.1016/j.ijrobp.2020.08.013.
doi: 10.1016/j.ijrobp.2020.08.013
|
[18] |
Lehrer EJ, Peterson JL, Zaorsky NG, et al. Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials[J]. Int J Radiat Oncol Biol Phys, 2019, 103(3): 618-630. DOI: 10.1016/j.ijrobp.2018.10.038.
doi: 10.1016/j.ijrobp.2018.10.038
|
[19] |
Andruska N, Kennedy WR, Bonestroo L, et al. Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases[J]. Radiother Oncol, 2021, 156: 181-187. DOI: 10.1016/j.radonc.2020.12.011.
doi: 10.1016/j.radonc.2020.12.011
|
[20] |
Yan M, Holden L, Wang M, et al. Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volume[J]. J Neurooncol, 2022, 159(3): 705-712. DOI: 10.1007/s11060-022-04115-3.
doi: 10.1007/s11060-022-04115-3
|